Addaven
Addaven is a medicine authorised by Swissmedic under authorisation number 65153. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 April 2015 and the authorisation is valid without a time limit. ATC code B05XA31 places the medicine in the group Blood substitutes and perfusion solutions.
| Authorisation number | 65153 |
|---|---|
| Name | Addaven |
| Full name | Addaven, Infusionskonzentrat |
| Authorisation holder | Fresenius Kabi (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B05XA31 |
| First authorisation | 10 April 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Addaven, Infusionskonzentrat | B | 10 April 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 x 10 | ml | B05XA31 | 07.01.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Addaven authorised in Switzerland?
Yes. Addaven is authorised by Swissmedic under authorisation number 65153, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Addaven have?
Addaven is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Addaven?
The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.